These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 38817874)
1. Identification and Validation of a Cancer-Testis Antigen-Related Signature to Predict the Prognosis in Stomach Adenocarcinoma. Bian G; Cao J; Li W; Huang D; Ding X; Zang X; Ye Y; Li P J Cancer; 2024; 15(11):3596-3611. PubMed ID: 38817874 [No Abstract] [Full Text] [Related]
2. A novel endoplasmic reticulum stress-related lncRNA signature for prognosis prediction and immune response evaluation in Stomach adenocarcinoma. Song Z; Su M; Li X; Xie J; Han F; Yao J BMC Gastroenterol; 2023 Dec; 23(1):432. PubMed ID: 38066437 [TBL] [Abstract][Full Text] [Related]
3. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma. Han C; Zhang C; Wang H; Li K; Zhao L BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056 [TBL] [Abstract][Full Text] [Related]
4. UBR1 is a prognostic biomarker and therapeutic target associated with immune cell infiltration in gastric cancer. Yuan W; Han J; Chen C; Qiu Y; Xu Y; Huang Y; Chen Z; Xu A; Sun M Aging (Albany NY); 2024 Aug; 16(16):12029-12049. PubMed ID: 39181686 [TBL] [Abstract][Full Text] [Related]
5. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets. Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of RNA methylation-related genes in gastric adenocarcinoma based on bioinformatics. He X; Chen X; Yang C; Wang W; Sun H; Wang J; Fu J; Dong H PeerJ; 2024; 12():e16951. PubMed ID: 38436027 [TBL] [Abstract][Full Text] [Related]
7. Amino acid metabolism-related genes as potential biomarkers and the role of MATN3 in stomach adenocarcinoma: A bioinformatics, mendelian randomization and experimental validation study. Zhu W; Fu M; Li Q; Chen X; Liu Y; Li X; Luo N; Tang W; Zhang Q; Yang F; Chen Z; Zhang Y; Peng B; Zhang Q; Zhang Y; Peng X; Hu G Int Immunopharmacol; 2024 Dec; 143(Pt 1):113253. PubMed ID: 39353384 [TBL] [Abstract][Full Text] [Related]
8. A 9‑gene expression signature to predict stage development in resectable stomach adenocarcinoma. Liu Z; Liu H; Wang Y; Li Z BMC Gastroenterol; 2022 Oct; 22(1):435. PubMed ID: 36241983 [TBL] [Abstract][Full Text] [Related]
9. Classification of stomach adenocarcinoma based on fatty acid metabolism-related genes frofiling. Liu C; Tao Y; Lin H; Lou X; Wu S; Chen L Front Mol Biosci; 2022; 9():962435. PubMed ID: 36090054 [No Abstract] [Full Text] [Related]
10. Identification of critical prognosis signature associated with lymph node metastasis of stomach adenocarcinomas. Wang X; Zhang W; Guo Y; Zhang Y; Bai X; Xie Y World J Surg Oncol; 2023 Feb; 21(1):61. PubMed ID: 36823639 [TBL] [Abstract][Full Text] [Related]
11. Single-cell data revealed CD14-type and FCGR3A-type macrophages and relevant prognostic factors for predicting immunotherapy and prognosis in stomach adenocarcinoma. Li M; Lu M; Li J; Gui Q; Xia Y; Lu C; Shu H PeerJ; 2024; 12():e16776. PubMed ID: 38274323 [TBL] [Abstract][Full Text] [Related]
12. Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration. Wang Z; Cao L; Zhou S; Lyu J; Gao Y; Yang R Front Immunol; 2022; 13():854785. PubMed ID: 35392086 [TBL] [Abstract][Full Text] [Related]
13. Construction of a prognostic risk model for Stomach adenocarcinoma based on endoplasmic reticulum stress genes. Li X; Lei Y Wien Klin Wochenschr; 2024 Jun; 136(11-12):319-330. PubMed ID: 37993598 [TBL] [Abstract][Full Text] [Related]
14. A 13-Gene Metabolic Prognostic Signature Is Associated With Clinical and Immune Features in Stomach Adenocarcinoma. Ye Z; Zheng M; Zeng Y; Wei S; Huang H; Wang Y; Liu Q; Lin Z; Chen S; Zheng Q; Chen L Front Oncol; 2021; 11():612952. PubMed ID: 34235071 [TBL] [Abstract][Full Text] [Related]
15. Identification of N6-Methylandenosine-Related lncRNAs for Subtype Identification and Risk Stratification in Gastric Adenocarcinoma. Huang Y; Yang Z; Huang C; Jiang X; Yan Y; Zhuang K; Wen Y; Liu F; Li P Front Oncol; 2021; 11():725181. PubMed ID: 34646770 [TBL] [Abstract][Full Text] [Related]
16. FDX1 as a novel biomarker and treatment target for stomach adenocarcinoma. Xie XZ; Zuo L; Huang W; Fan QM; Weng YY; Yao WD; Jiang JL; Jin JQ World J Gastrointest Surg; 2024 Jun; 16(6):1803-1824. PubMed ID: 38983344 [TBL] [Abstract][Full Text] [Related]
17. Constructing a novel gene signature derived from oxidative stress specific subtypes for predicting survival in stomach adenocarcinoma. Zhou R; Peng N; Li W Front Immunol; 2022; 13():964919. PubMed ID: 36059494 [TBL] [Abstract][Full Text] [Related]
18. Construction of stomach adenocarcinoma prognostic signature based on anoikis-related lncRNAs and clinical significance. Lu L; Yu M; Huang W; Chen H; Jiang G; Li G Libyan J Med; 2023 Dec; 18(1):2220153. PubMed ID: 37300839 [TBL] [Abstract][Full Text] [Related]
19. Construction and validation of a glycolysis-related lncRNA signature for prognosis prediction in Stomach Adenocarcinoma. Liao T; Lu Y; Li W; Wang K; Zhang Y; Luo Z; Ju Y; Ouyang M Front Genet; 2022; 13():794621. PubMed ID: 36313430 [No Abstract] [Full Text] [Related]
20. High Expression of ERK-related RASGRF2 predicts Poor prognosis in patients with Stomach Adenocarcinoma and correlates with M2 macrophage. Du Y; Wang Z; Wan W J Cancer; 2021; 12(23):7177-7189. PubMed ID: 34729119 [No Abstract] [Full Text] [Related] [Next] [New Search]